ACE2 and COVID-19: It has been proposed that the loss of ACE2 is related to lung injury, where negative regulation and the decline of this enzyme may lead to dysfunction of the renin‐angiotensin system and potentially impair vascular function in COVID‐19 individuals (Gladka & Maack, 2020).